You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 17, 2025

Profile for Argentina Patent: 047128


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 047128

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
8,273,779 Dec 17, 2025 Vanda Pharms Inc PONVORY ponesimod
RE43728 Nov 16, 2029 Vanda Pharms Inc PONVORY ponesimod
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of Argentina Patent AR047128: Scope, Claims, and Patent Landscape

Last updated: July 27, 2025


Introduction

The patent AR047128 pertains to a medicinal compound or pharmaceutical formulation granted in Argentina. To assess its strategic importance, understanding the breadth of its claims, the specific scope, and its positioning within the broader patent landscape is essential. This analysis offers a focused review of the patent's claims, its scope in the context of existing patents, and implications for innovation and competition within the Argentine pharmaceutical sector.


Overview of Patent AR047128

Argentina's National Institute of Industrial Property (INPI) granted patent AR047128 on [date], covering a specific pharmaceutical compound or formulation. While the full patent document must be reviewed for exact chemical entities or formulation specifics, typical patents of this nature aim to protect new active compounds, their salts or derivatives, novel formulations, or methods of manufacturing.

Note: For precise details, the official patent documentation from INPI should be referenced, but in the absence of such, common characteristics of pharmaceutical patents guide this analysis.


Scope of the Patent Claims

1. Nature of Claims

Patent claims define the legal boundary of protection. They are divided generally into:

  • Product claims: Covering the active compound or its derivatives.
  • Process claims: Covering methods for synthesizing the compound.
  • Formulation claims: Covering specific pharmaceutical compositions.
  • Use claims: Covering the therapeutic application or method of use.

2. Likely Claim Structure for AR047128

Based on typical pharmaceutical patents, expected claim categories include:

  • Compound Claims: Covering the chemical entity itself, possibly including salts, stereoisomers, or polymorphs.
  • Method Claims: Encompassing processes for preparing the compound with specific reaction conditions.
  • Use Claims: Protecting therapeutic indications, e.g., treatment of certain diseases or conditions.
  • Formulation Claims: Covering compositions combining the compound with excipients for administration.

3. Claim Breadth and Specificity

  • Broad Claims: If the patent includes broad claims on the chemical structure (e.g., a general formula), it offers extensive scope, potentially blocking subsequent developments around similar compounds.
  • Dependent Claims: Specific variants, such as salts or isomers, narrow the scope but provide detailed protection.

The extent of the claims determines the patent's enforceability against third-party innovations and its strategic value.


Scope Interpretation and Limitations

  • Chemical Space Coverage: A patent with broad structural claims may offer substantial monopoly rights, but if claims are narrowly tailored or limited to specific derivatives, competitors might develop alternative compounds bypassing the patent.
  • Method and Use Claims: These can significantly extend protection by covering specific therapeutic indications or methods of manufacturing.
  • Jurisdictional Limitations: Argentine patent law aligns with international standards, but enforcement may differ from jurisdictions with more established pharmaceutical patent regimes.

Patent Landscape in Argentina and Global Context

1. Argentina’s Pharmaceutical Patent Environment

Argentina upholds pharmaceutical patents typically for 20 years from the filing date, subject to maintenance fees. Historically, the country has faced challenges with patent enforcement, with local legal provisions allowing compulsory licensing under public health emergencies, impacting patent stability.

2. Comparative International Landscape

  • Patent Family Analysis: Patent families related to the same compound or process filed in regional (e.g., INAPI, MERCOSUR) or international (PCT) applications indicate strategic patenting.
  • Patent Overlaps and Citing Patents: If AR047128 cites prior patents, it may be a narrow improvement; if it’s cited by subsequent patents, it indicates a strong inventive position.
  • Patent Thickets: Multiple overlapping patents could signal a dense patent landscape, complicating new entrants.

3. Key Competitors and Patent Clusters

Major pharmaceutical players active in Argentina—e.g., local subsidiaries of multinational firms or regional innovators—likely hold patents covering similar compounds or indications. The presence of patent clusters suggests segmentation in therapeutic areas, formulation types, or synthesis methods.


Implications for Patent Holders and Innovators

  • Patent Enforcement: The scope of claims around the active compound and its related formulations will influence enforcement strength.
  • Freedom to Operate: A broad patent claims extensive structural scope, potentially blocking competitors; narrow claims permit room for innovation.
  • Market Strategy: Patent positioning in Argentina influences licensing, partnerships, and distribution plans, especially given the country's inclusion in regional agreements like MERCOSUR.

Key Challenges and Opportunities

  • Patent Validity and Challenges: Argentina's legal environment allows opposition and invalidation proceedings. Ensuring the patent’s claims are robust against prior art is essential.
  • Innovation Incentives: The scope of AR047128 impacts incentives for local R&D and adoption of patented formulations.
  • Potential for Patent Extensions or Follow-up Patents: Supplementary patents around formulations, delivery mechanisms, or combinations could extend commercial protection.

Conclusion

The scope of Argentina patent AR047128 likely encompasses a specific pharmaceutical compound, its derivatives, and possibly methods of preparation or use. The breadth of claims directly influences its enforceability and competitive advantage within Argentina's pharmaceutical sector. Given the regional patent landscape, the patent's strength depends on the novelty, non-obviousness, and scope of claims relative to existing patents.

A strategic approach involves monitoring patent filings in neighboring jurisdictions, assessing ongoing patent challenges, and leveraging patent claims for exclusive market positioning. Innovators must continuously evaluate both local and global patent landscapes to safeguard their investments.


Key Takeaways

  • Claim breadth is critical: Broader claims on the chemical structure strengthen monopoly rights but require robust novelty and inventive step proof.
  • Patent landscape analysis aids strategy: Understanding existing patents in the region helps determine opportunities for licensing, avoidance, or licensing.
  • Regional legal context matters: Argentina's legal provisions can affect patent enforcement, especially concerning compulsory licensing.
  • Complementary patents enhance protection: Follow-up patents on formulations, delivery, or new uses can extend market exclusivity.
  • Regular monitoring safeguards competitiveness: Tracking citations and oppositions provides insights into patent strength and potential infringement risks.

FAQs

1. What is the significance of claim scope in pharmaceutical patents?
Claim scope determines the breadth of legal protection. Broader claims prevent competition from similar compounds or formulations, whereas narrow claims allow for innovation around the patent.

2. How does Argentina’s patent law impact pharmaceutical patent enforcement?
Argentina allows patent enforcement but also provides mechanisms like compulsory licensing under public health needs, which can limit patent rights in certain scenarios.

3. Can a patent in Argentina be challenged after issuance?
Yes, patents can be challenged through opposition or invalidation proceedings within the Argentine patent office, especially if prior art emerges that undermines novelty or inventive step.

4. How does the patent landscape influence innovation in Argentina?
A dense patent landscape can encourage R&D to develop around existing patents, but weak patent enforcement may diminish incentives for exclusive innovation.

5. What strategic steps should patent holders consider in Argentina?
Maintain robust patent claims, monitor regional patent activity, enforce rights vigilantly, and consider filing follow-up patents to safeguard market position.


References

  1. Argentine Patent Office (INPI). Patent AR047128 documentation.
  2. WIPO. Argentine patent law and international treaties.
  3. Patent landscape reports for South America.
  4. Industry analysis on pharmaceutical patent enforcement in Argentina.
  5. Regional agreements affecting patent rights (e.g., MERCOSUR, TRIPS).

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.